Innovative procedure outperforms drugs for advanced atrial fibrillation
A minimally invasive heart procedure may be a better first-line treatment than medication for people living with advanced forms of…
A minimally invasive heart procedure may be a better first-line treatment than medication for people living with advanced forms of…
Mount Sinai researchers developed an AI model to make individualized treatment recommendations for atrial fibrillation (AF) patients—helping clinicians accurately decide…
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many…
Three common cardiovascular diseases in adults—heart failure, atrial fibrillation and coronary heart disease—are linked to cognitive impairment and increased risk…
Patients with atrial fibrillation (Afib) who took low doses of blood-thinning medications known as direct oral anticoagulants (DOACs) experienced more…
Although the vast majority of clinicians do not view atrial fibrillation (AF) as a genetic disorder, a White Paper in…
Atrial fibrillation (AF) is a major global health concern impacting millions and causing symptoms like palpitations, dyspnea, fatigue, dizziness, and…
Atrial fibrillation (AF) diagnosis was associated with a 45% increased risk of mild cognitive impairment (MCI) among a cohort of…
Findings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing a transcatheter aortic valve replacement…
A large-scale international study led by Mount Sinai has yielded the first risk score that can help predict mortality for…
Atrial fibrillation can be detected during annual foot assessments in patients with diabetes, according to research presented today at EHRA…